Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in acute intracerebral hemorrhage
IRCT20141116019971N6Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of atorvastatin in intracerebral hemorrhage (ICH) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Serum matrix metallopeptidase 9 level and Serum vascular endothelial growth factor level. Started Jul 2022; status: completed.
02
Drugs
atorvastatin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on IRCT20141116019971N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141116019971N6.